• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625

Research Briefing on 3,5-Dimethyl-1-propyl-1H-pyrazol-4-amine hydrochloride (CAS: 1269105-97-6): Recent Advances and Applications

3,5-Dimethyl-1-propyl-1H-pyrazol-4-amine hydrochloride (CAS: 1269105-97-6) is a pyrazole derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential therapeutic applications. This compound, characterized by its unique structural features, has been the subject of recent studies exploring its pharmacological properties, synthetic pathways, and mechanisms of action. This briefing aims to provide a comprehensive overview of the latest research developments related to this compound, highlighting its relevance in drug discovery and development.

Recent studies have focused on the synthesis and optimization of 3,5-Dimethyl-1-propyl-1H-pyrazol-4-amine hydrochloride to enhance its bioavailability and therapeutic efficacy. Researchers have employed advanced synthetic techniques, including microwave-assisted synthesis and catalytic methods, to achieve high yields and purity. The compound's structural versatility allows for further derivatization, making it a promising scaffold for the development of novel bioactive molecules. These efforts are supported by computational modeling and in vitro assays to predict and validate its interactions with biological targets.

Pharmacological investigations have revealed that 3,5-Dimethyl-1-propyl-1H-pyrazol-4-amine hydrochloride exhibits notable activity against a range of biological targets, including enzymes and receptors implicated in inflammatory and neurodegenerative diseases. For instance, recent in vivo studies have demonstrated its potential as an anti-inflammatory agent, with mechanisms involving the modulation of key signaling pathways such as NF-κB and MAPK. Additionally, its neuroprotective effects have been explored in models of Alzheimer's disease, suggesting its utility in addressing unmet medical needs in neurology.

The compound's safety profile and pharmacokinetic properties have also been evaluated in preclinical studies. Results indicate favorable absorption and distribution characteristics, with minimal off-target effects. These findings underscore its potential as a lead compound for further clinical development. Collaborative efforts between academic institutions and pharmaceutical companies are underway to advance this molecule through the drug development pipeline, with a focus on optimizing its formulation and delivery systems.

In conclusion, 3,5-Dimethyl-1-propyl-1H-pyrazol-4-amine hydrochloride represents a promising candidate in the realm of medicinal chemistry, with diverse applications spanning anti-inflammatory, neuroprotective, and potentially other therapeutic areas. Ongoing research continues to uncover its full potential, paving the way for future innovations in drug discovery. This briefing underscores the importance of interdisciplinary collaboration and cutting-edge methodologies in advancing the understanding and application of this compound.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)